The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys
Abstract
In search of metabolically regulated secreted proteins, we conducted a microarray study comparing gene expression in major metabolic tissues of fed and fasted ob/ob mice and C57BL/6 mice. The array used in this study included probes for ~4000 genes annotated as potential secreted proteins. Circulating macrophage inhibitory cytokine 1 (MIC-1)/growth differentiation factor 15 (GDF15) concentrations were increased in obese mice, rats, and humans in comparison to age-matched lean controls. Adeno-associated virus-mediated overexpression of GDF15 and recombinant GDF15 treatments reduced food intake and body weight and improved metabolic profiles in various metabolic disease models in mice, rats, and obese cynomolgus monkeys. Analysis of the GDF15 crystal structure suggested that the protein is not suitable for conventional Fc fusion at the carboxyl terminus of the protein. Thus, we used a structure-guided approach to design and successfully generate several Fc fusion molecules with extended half-life and potent efficacy. Furthermore, we discovered that GDF15 delayed gastric emptying, changed food preference, and activated area postrema neurons, confirming a role for GDF15 in the gut-brain axis responsible for the regulation of body energy intake. Our work provides evidence that GDF15 Fc fusion proteins could be potential therapeutic agents for the treatment of obesity and related comorbidities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Altered GDF-15 levels in comparison to matched lean controls have been frequently reported in obese mice, rats, and humans (32, 105).”
From GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin (2020) · cites this paper as [32]
In the citing paper
“In line with these studies, exogenous administration of recombinant murine or human GDF-15 induced weight loss in different animal models (26, 32, 40, 41, 107).”
From GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin (2020) · cites this paper as [32]
In the citing paper
“Elevated circulating GDF-15 levels have been associated with more severe disease or higher mortality in people with DM2, insulin resistance, hemodialysis, cachexia, cardiovascular diseases, chronic obstructive pulmonary disease (COPD), venous thromboembolism (VTE), cancer, or obesity (28–34).”
From GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin (2020) · cites this paper as [32]
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The CCP4 suite: programs for protein crystallography
Number Collaborative Computational Project (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,317
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,796
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily
Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S. M., Pryor, K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11514 · Cited by 1,180
Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
Johnen, H., Lin, S., Kuffner, T., Brown, D. A., Tsai, V. W.-W., Bauskin, A. R., Wu, L., Pankhurst, G., Jiang, L., Junankar, S., et al. (2007) · Nature Medicine · doi:10.1038/nm1677 · Cited by 612
Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
Wollert, K. C., Kempf, T., & Wallentin, L. C. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.255174 · Cited by 569
Crystal Structure of Transforming Growth Factor-β2: an Unusual Fold for the Superfamily
Daopin, S., Piez, K. A., Ogawa, Y., & Davies, D. R. (1992) · Science · doi:10.1126/science.1631557 · Cited by 440
Anatomy and physiology of the enteric nervous system
Costa, M., Brookes, S., & Hennig, G. (2000) · Gut · doi:10.1136/gut.47.suppl_4.iv15 · Cited by 364
Cited by
Sorted by citations
Items 201–236 of 236
Peng, B., Zhao, W., Kong, M., Chen, Y., & Sun, C. (2026) · British Journal of Biomedical Science · doi:10.3389/bjbs.2026.16085 · Cited by 1
(2018) · International journal of research studies in biosciences · doi:10.20431/2349-0365.0602004
GDF15 in Vascular and Liver Metabolic Disorders: A Novel Therapeutic Target
Fiorucci, S., & Urbani, G. (2022) · Recent Advances in Inflammation & Allergy Drug Discovery · doi:10.2174/277227081602221221113442 · Cited by 2
Growth Differentiation Factor 15 As Promising Biomarker Of Poor Prognosis In Heart Failure
Berezin, A. Е. (2018) · Journal of Cardiology and Therapy · doi:10.17554/j.issn.2309-6861.2018.05.149 · Cited by 1
Papers of note in Science Translational Medicine 9 (412)
Ferrarelli, L. K. (2017) · Science Signaling · doi:10.1126/scisignal.aar2008
Promising utilities of growth differentiation factor 15 in cardiovascular diseases
Berezin, A. Е. (2018) · Biological Markers and Guided Therapy · doi:10.12988/bmgt.2018.811
The Effects of Induced Polycystic Ovary Syndrome in NAG-1 Transgenic Mice
Werner, N. (2020) · ScholarWorks (Central Washington University)
Wright, D. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.739567955.793584414
Kralisch, S., & Blüher, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-57401-7_176
Ladbury, J. E. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737907472.793574673
Kralisch, S., & Blüher, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-21573-6_176-1
Gestational Transient Hyperthyroidism
Karras, S. Ν., & Tzotzas, T. (2022) · Springer eBooks · doi:10.1007/978-3-030-98777-0_10
Activity-Balanced GLP-1/GDF15 Dual Agonist to Treat Obesity in Mice and Non-Human PrimatesPreprint
Zhang, Y., Zhao, X., Dong, X., Zhang, Y., Zou, H., Jin, Y., Guo, W., Zhai, P., Chen, X., & Kharitonenkov, A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4126596
GDF15 mediates renal cell plasticity in response to potassium depletionPreprint
Lasaad, S., Walter, C., Rafael, C., Morla, L., Doucet, A., Picard, N., Blanchard, A., Fromes, Y., Matot, B., Crambert, G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.27.521983
บทบาทของ growth differentiation factor 15 (GDF-15) ในการวนจฉยการปฏเสธเนอเยอในผปวยหลงปลกถายหวใจ
โตควณิชย์, น., & ภูวนันท์, ศ. (2019) · doi:10.58837/chula.the.2019.1484
Çetiner, S. (2023) · Eurasian Journal of Medical Investigation · doi:10.14744/ejmi.2023.59132
Ayaz, E., Görkem, Ü., Kan, Ö., Toğrul, C., ŞİMŞEK, Ü., & Han, O. (2024) · Hitit Medical Journal · doi:10.52827/hititmedj.1363447
Fu, W., Yang, Y., Guo, X., Gong, Q., Zhou, X., Zhou, L., Liu, C., Zhang, Z., So, J., Zhang, Y., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.07.579397
He, G., Zeng, F., Lan, J., Tang, X., & Guo, X. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5109229
Fink, K., Braun, T., Herkel, M., Duerschmied, D., Busch, H.-J., & Helbing, T. (2025) · Research Square · doi:10.21203/rs.3.rs-6810991/v1
Boutari, C., Stefanakis, K., Simati, S., Guatibonza-García, V., Valenzuela‐Vallejo, L., Anastasiou, I. A., Connelly, M. A., Kokkinos, A., & Mantzoros, C. S. (2024) · Figshare · doi:10.6084/m9.figshare.26722629
Salmón‐Gómez, L., Gómez‐Ambrosi, J., Frühbeck, G., & Catalán, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00346-0
Wu, Q., Yang, K., Liao, X., Zheng, S., Zheng, X., Wang, H., Yang, J., & Hong, T. (2026) · Biomedicines · doi:10.3390/biomedicines14030572
Self-citationSmall-molecule inhibition of the deadenylase CNOT6L as a strategy of obesity treatment
Zhang, H., Zhao, J., Li, Y., Yuan, M., Lei, W., & Yang, S.-Y. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.04.008
Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases
Chui, Z. S. W., Xue, Y., Wu, X., & Xu, A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100150
A Lineup for Next Anti-Obesity Medicines: Beyond Incretin-Based Pharmacotherapy
Lee, S. M., Song, H., & Kwon, Y. O.-S. (2026) · Pharmaceuticals · doi:10.3390/ph19071047
Lipid sensing and brain hormone receptors in food intake and glucose regulation
Garrido, A. N., Lyons, S. A., MOSLEMIAN, D., Beaudry, J. L., & Lam, T. K. T. (2026) · Nature Reviews Endocrinology · doi:10.1038/s41574-026-01278-1
GDF15 in Liver Fibrosis: Molecular Mechanisms, Immunoregulatory Functions, and Therapeutic Potential
Gan, X., Zhang, L., Yu, T., Jin, S., Wu, Y., Xu, R., Zhang, Y., Zhang, J., Xu, L., & Wang, X. (2026) · Biomolecules · doi:10.3390/biom16071060
Self-citationGDF15: A Hijacked Metabo-Hormone Orchestrating Cachexia and Immunosuppression in Cancer
Qi, D.-Y., Wang, Y., & Jin, W. (2026) · Biomolecules · doi:10.3390/biom16071070
Ahad, A., Hullon, D., Akhavan, M., & Oskouyan, Z. (2026) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-026-10839-8 · Cited by 1
Nie, T., 宋红梅, Shen, X., & Mao, L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1885104
Bonaventura, I., Weigand, I., Isidori, A. M., Kroiß, M., & Reincke, M. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag035
Giesy, S. L., Opgenorth, J., Rodríguez-Jiménez, S., Baumgard, L. H., Swartz, T. H., Mamedova, L. K., Bradford, B. J., Ferro, L. N., Overton, T. R., Rial, C., et al. (2026) · Journal of Dairy Science · doi:10.3168/jds.2026-29128
Biological functions and emerging interplay of FGF21 and GDF15 in metabolic diseases and aging
Salmón‐Gómez, L., Keipert, S., Catalán, V., Rodrı́guez, A., Becerril, S., Frühbeck, G., & Gómez‐Ambrosi, J. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00627-w
Metadata
- Authors
- Xiong, Y., Walker, K., Min, X., Hale, C., Tran, T., Komorowski, R., Yang, J., Davda, J., Nuanmanee, N., Kemp, D., Wang, X., Liu, H., Miller, S., Lee, K. J., Wang, Z., & Véniant, M. M.
- Affiliations
- Amgen (United States) (US)
- Department of Cardiometabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
- Corresponding author
- Véniant, Murielle M.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2017-10-18
- Volume
- 9
- Issue
- 412
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2765137069
- Cited by
- 236
- References
- 38
- Citations by year
- 2026: 20 · 2025: 28 · 2024: 25 · 2023: 35 · 2022: 32 · 2021: 23 · 2020: 31 · 2019: 24 · 2018: 16 · 2017: 2
- FWCI
- 17.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- GDF15, MIC-1, obesity, Fc fusion protein, adeno-associated virus gene therapy, dietary intake, body weight, gut-brain axis, gastric emptying, food preferences, secreted proteins, Macaca fascicularis, structure-guided protein engineering
- MeSH terms
- Dependovirus, Animals, Diet, Food Preferences, Gastric Emptying, Humans, Macaca fascicularis, Male, Mice, Inbred C57BL, Mice, Obese, Neurons, Obesity, Receptors, Fc, Recombinant Fusion Proteins, Up-Regulation, Rats, Sprague-Dawley, Crystallography, X-Ray, Growth Differentiation Factor 15
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
